Product Information
CLARITHROMYCIN 250 MG TABLET is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.3939 per EA under NDC 62332034460. Its NADAC has been published 221 times since Jul 13, 2022.
FDA first approved this application on Jan 31, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332034460
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CLARITHROMYCINApproval Type
Generic (ANDA)
FDA Application
ANDA210459FDA Approved
1/31/2022
TE Code
AB
On Market Since
2/1/2022
Pharmacological Classes
Price Statistics
The NADAC for CLARITHROMYCIN 250 MG TABLET has been published 221 times since Jul 13, 2022, and over the history we have for it it has declined 31.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3939 per EA |
|---|---|
| All-time high | $0.8146 (Feb 15, 2023) |
| All-time low | $0.3332 (Nov 20, 2024) |
| 52-week high | $0.5102 |
| 52-week low | $0.3421 |
| Median price | $0.4696 |
| Average price | $0.4982 |
| Largest weekly change | +73.4% (Jan 18, 2023) |
| Weeks tracked | 221 |
| Tracking since | Jul 13, 2022 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alembic Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Clarithromycin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Macrolide Antimicrobial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLARITHROMYCIN 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CLARITHROMYCIN 250 MG TABLET, manufactured by Alembic Pharmaceuticals Inc., is $0.3939 per EA (NDC 62332034460), effective Sep 30, 2026.
How has the price of CLARITHROMYCIN 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for CLARITHROMYCIN 250 MG TABLET has declined 31.1%. It has been tracked across 221 weekly CMS publications since Jul 13, 2022.
What are the highest and lowest recorded NADAC prices for CLARITHROMYCIN 250 MG TABLET?
Since Jul 13, 2022, the NADAC for CLARITHROMYCIN 250 MG TABLET has ranged from a low of $0.3332 (Nov 20, 2024) to a high of $0.8146 (Feb 15, 2023), with a median of $0.4696 per EA.
Are there cheaper alternatives to CLARITHROMYCIN 250 MG TABLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLARITHROMYCIN 250 MG TABLET, is $0.3707 per EA — about 6% below CLARITHROMYCIN 250 MG TABLET.
Who manufactures CLARITHROMYCIN 250 MG TABLET?
CLARITHROMYCIN 250 MG TABLET (NDC 62332034460) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.